Western blot results in Figure 5(a) showed that the protein expressions of PPAR-γ were significantly decreased, and SREBP-1 and p-AKT were significantly increased in the NAFLD group compared to the control group (P < 0.01). The gene discussed is SREBF1; the disease is metabolic dysfunction-associated steatotic liver disease.